Review of aggression management in an emergency setting;Revisión del manejo de la agresividad patológica en situación de urgencia

Actas Espanolas de Psiquiatria

Volumn 33, Issue 3, 2005, Pages 194-200

  Fernandez Garcia De Las Heras V ^a   Mendiola Munoa N ^a   Ramirez Reinoso M ^a   Valle Fernandez J ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

Agression; Behavioral emergencies; Management

Indexed keywords

AGGRESSION; DECISION MAKING; EMERGENCY HEALTH SERVICE; HEALTH CARE PERSONNEL; HUMAN; MENTAL HEALTH; PRACTICE GUIDELINE; REVIEW;

AGGRESSION; ANTIPSYCHOTIC AGENTS; EMERGENCY SERVICES, PSYCHIATRIC; HEALTH FACILITIES; HUMANS; MENTAL DISORDERS;

EID: 21544474982     PISSN: 11399287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. Citrome L, Volavka J. Aggression (on line). Febrero 2002 (fecha de acceso 21 de octubre 2002). Disponible en URL; http://www.emedicine.com/med/topic3005. htm.
2. Buchanan A, Leese M. Detention of people with dangerous severe personality disorders: a systematic review. Lancet 2001;358:1955-9.
3. Hughes D. Suicide and violence assessment in psychiatry. Gen Hosp Psychiatry 1996;18:416-21.
4. Nijman H, Merckelbach H, Evers C, Palmstierna T, Campo AJ. Prediction of aggression on a locked psychiatric admission ward. Acta Psychiatr Scand 2002;105:390-5.
5. Davis S. Violence by psychiatric inpatients: a review. Hosp Community Psychiatry 1991;42:585-90.
6. McNeil DE, Binder RL. The relationship between acute psychiatric symptoms, diagnosis, and short-term risk of violence. Hosp Community Psychiatry 1994;45:133-7.
7. Tardiff K, Swelliam A. The occurrence of assaultive behavior among chronic psychiatric inpatients. Am J Psychiatry 1982;139:212-5.
8. Elliot FA. Violence: the neurologic contribution: an overview. Arch Neurol 1992;49:595-603.
9. rd ed. Washington: American Psychiatric Press, 1999.
10. McNiel D. Correlates of violence in psychotic patients. Psychiatr Ann 1997;27:683-90.
11. Taylor PJ. Schizophrenia and the risk of violence. En: Hirsh SR, Weinberger DR, editores. Schizophrenia. Oxford (England): Blackwell Science, 1995; p. 163-83.
12. Weiden PJ, Olfson M. Cost of relapse in schizophrenia. Schizophr Bull 1995;21:419-29.
13. Swanson J, Holzer C, Gantu V, et al. Violence and psychiatric disorder in the community: evidence from the epidemiologic catchment area surveys. Hosp Community Psychiatry 1990; 41:761-70.
14. Harris GT, Rice ME. Risk appraisal and management of violent behavior. Psychiatric Serv 1997;48:1168-76.
15. Hughes DH, Kleespies PM. Treating aggression in the psychiatric emergency service. J Clin Psychiatry 2003;64(Suppl. 4):10-5.
16. Yehuda R. Managing anger and aggression in patients with posttraumatic stress disorder. J Clin Psychiatry 1999;60(Suppl. 15):33-7.
17. Lavine R. Psychofarmacological treatment of aggression and violence in the substance using population. J Psychoactive Drugs 1997;29:321-9.
18. Hollander E. Managing aggressive behavior in patients with obsessive-compulsive disorders and borderline personality disorder. J Clin Psychiatry 1999;60(Suppl. 15):38-44.
19. Fisher WA. Restraint and seclusion: a review of the literature. Am J Psychiatry 1994;151:1584-91.
20. Way BB, Banks SM. Use of seclusion and restraint in public psychiatric hospitals: patient characteristics and facility effects. Hosp Community Psychiatry 1990;41:75-81.
21. Allen MH, Currier GN, Hughes DH, Reyer-Harde M, Docherty JP, Ross RW. The Expert Consensus Guideline Series. Treatment of behavioral emergencies. Postgrad Med 2001 (spec No):1-88.
22. American Psychiatric Nurses Association (2000). Position statement on the use of seclusion and restraint. Disponible en URL; http://www.apna.org.
23. American Psychiatric Nurses Association (2003). Learning from each other: success stories and ideas for reducing restraint/seclusion in behavioral health. Disponible en URL; http://www.apna.org.
24. Tinetti ME, Liu WL, Ginter SF. Mechanical restraint use among residents of skilled nursing facilities: prevalence, patterns, and predictors. JAMA 1991;265:468-71.
25. Miller D, Walker MC, Friedman D. Use of holding technique to control the violent behavior of seriously disturbed adolescents. Hosp Community Psychiatry 1989;40:520-4.
26. Dabrowski S, Frydman L, Zakowska-Dabrowska T. Physical restraint in Polish psychiatric facilities. Int J Law Psychiatry 1986;8:369-82.
27. Sailas E, Fenton M. Seclusion and restraint for people with serious mental illness (Cochrane review). The Cochrane Library, issue 4, 2002. Oxford.
28. Joint Commission on the Accreditation of Healthcare Organizations. Comprehensive Accreditation Manual for Hospitals (CMAH). Available in URL; http://www.jcaho.org.
29. US Department of Health and Human Services, Health Care Financing Administration. Hospital Conditions of Participation for Patient's Rights. 42CFR 482.13. Baltimore, MD: HCFA; 1999. Disponible en URL; http://www.hcfa.gov/ quality/4b2.htm.
30. Royal College of Psychiatrist. Management of imminent violence: clinical practice guidelines to support mental health services. College Research Unit. Occasional paper OP41. London, 1998.
31. Wright S. Control and restraint techniques in the management of violence in inpatient psychiatry: a critical review. Med Sci Law 2003;43:31-8.
32. McAllister-Williams RH, Ferrier IN. Rapid tranquilisation: time for a reappraisal of options for parenteral therapy. Br J Psychiatry 2002;180:485-9.
33. Battaglia J, Moss S, Rush J, et al. Haloperidol, lorazepam, or both for psychotic agitation? A multicenter, prospective, double-blind, emergency study. Am J Emerg Med 1997;15:335-40.
34. Biernek SA, Ownby RL, Penlaver A, et al. A double-blind study of lorazepam versus the combination of haloperidol and lorazepam in managing agitation. Pharmacotherapy 1998;18:57-62.
35. Buckley PF. The role of typical and atypical antipsychotic medications in the management of agitation and aggression. J Clin Psychiatry 1999;60(Suppl. 10):52-60.
36. Allen MH. Managing the agitated psychotic patient: a reappraisal of the evidence. J Clin Psychiatry 2000;61(Suppl. 14):11-20.
37. Kamin J, Manwani S, Hughes D. Extrapyramidal side effects in the psychiatric emergency service. Psychiatr Serv 1999;50:1553-4.
38. Baldessarini RJ, Cohen BM, Teicher MH. Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychosis. Arch Gen Psychiatry 1988;45:79-91.
39. Czobor P, Volavka J, Meibach RC. Effect of risperidone on hostility in schizophrenia. J Clin Psychopharmacol 1995;15:243-9.
40. Seeman P. Atypical antipsychotics: mechanism of action. Can J Psychiatry 2002;47:27-38.
41. Citrome L, Volavka J, Czobor P, Sheitman B, Lindenmayer JP, McEvoy J, et al. Effects of clozapine, olanzapine, risperidone and haloperidol on hostility among patients with schizophrenia. Psychiatr Serv 2001;52:1510-4.
42. Glazer WM, Dickson RA. Clozapine reduce violent and persistent aggression in schizophrenia. J Clin Psychiatry 1998;58(Suppl. 3): 8-14.
43. Buckley PF, Ibrahim Zy, Singer B, Orr B, Donenwirth, Brar P. Aggression and schizophrenia: efficacy of risperidone. J Am Psychiatry Law 1997;25:173-81.
44. Chengappa KNR, Levine J, Ulrich R, et al. Impact of risperidone on seclusion and restraint at a state psychiatric hospital. Can J Psychiatry 2000;45:827-32.
45. Wright P, Birkett M, David SP, et al. Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia. Am J Psychiatry 2001;158:1149-51.
46. Brook S, Lucey JV, Gunn KP, for the Ziprasidone I. M. Study Group. Intramuscular ziprasidone compared with intramuscular haloperidol in the treatment of acute psychosis. J Clin Psychiatry 2000;61:933-41.
47. Daniel D, Potkin S, Reeves K, Swift R, Harrigan E. Intramuscular ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind randomized trial. Psychopharmacology 2001;155:128-34.
48. Lesem MD, Zajecka JM, Swift RH, et al. Intramuscular ziprasidone, 2 mg versus 10 mg, in the short-term management of agitated psychotic patients. J Clin Psychiatry 2001;62:12-8.
49. Farnham FR, James DV. «Dangerousness» and dangerous law [comment]. Lancet 2001;358:1926.